Latest news with #Thin
Yahoo
4 days ago
- Business
- Yahoo
Industrial Crystallizers Market to Reach USD 5.87 Billion by 2032 with a CAGR of 4.67%, Driven by Demand for High-Purity Materials and Wastewater Treatment Innovations
Industrial Crystallizers Market is experiencing significant growth driven by the increasing need for high-purity substances in the chemical, pharmaceutical, and food industries. As industrial processes become more complex, crystallization technologies are essential for efficient separation and purification. Austin, May 27, 2025 (GLOBE NEWSWIRE) -- The Industrial Crystallizers Market Size was valued at USD 3.91 billion in 2023 and is expected to reach USD 5.87 billion by 2032, growing at a CAGR of 4.67% over the forecast period from 2024 to PDF Sample of Industrial Crystallizers Market @ The industrial crystallizers market is growing due to the need for high-purity substances, especially in the pharmaceuticals and chemicals industries. The rising use of crystallization technologies in the treatment of wastewater and the food industry also drives up market demand. Forced circulation systems and continuous processes are notable advancements in crystallizer design and are finding their way into mass production owing to their improved efficiency, scalability, higher yield quality consistency, as well as secondary treatment mechanisms, which are driving growth in the key regions across the globe. U.S. Industrial Crystallizers Market to Reach USD 1.07 Billion by 2032 with 6.15% CAGR The U.S. Industrial Crystallizers Market reached USD 0.63 billion in 2023 and is expected to reach USD 1.07 billion by 2032, advancing at a CAGR of 6.15% from 2024 to 2032. The U.S. market for industrial crystallizers is a key driver of global growth, spurred by innovation in chemical production, pharmaceuticals, and wastewater treatment. Key Players: Tsukishima Kikai – (OS Crystallizer, Vacuum Cooling Crystallizer) Fives Group – (Evaporative Crystallizer, Solios Forced Circulation Crystallizer) Condorchem Envitech – (ENVIDEST MVR FC Crystallizer, Vacuum Crystallization Plant) Vobis LLC – (Pilot Plant Crystallizer, Continuous Crystallizer System) Anssen Metallurgy Group Co., Ltd. – (Vacuum Salt Crystallizer, Evaporation & Crystallization System) Boardman LLC – (Forced Circulation Crystallizer, Industrial Heat Exchanger Crystallizer) Chemin Enviro Systems Pvt. Ltd. – (Forced Circulation Crystallizer, Agitated Thin Film Dryer-Crystallizer Combo) DCI, Inc. – (Batch Crystallizer Tank, Jacketed Stainless Steel Crystallizer) Ebner GmbH & Co. KG – (Vacuum Crystallizer, Controlled Cooling Crystallizer) Ekato Holding GmbH – (EKATO ISOPAS Crystallizer, EKATO UNIMIX Processing Crystallizer) Excel Engineering – (MS ZLD Crystallizer, Multiple Effect Evaporator with Crystallizer) GEA Group – (GEA MSE Crystallizer, VARICHEMA Batch Crystallizer) Katsuragi Industry Co., Ltd. – (Stainless Steel Crystallizer Tank, Continuous Crystallizing Unit) KEP Engineering Services Pvt. Ltd. – (Forced Circulation Crystallizer, Agitated Crystallizer) Moretto S.p.A. – (XD 800 X Dryer-Crystallizer, DEGA Thermal Crystallizer) Motan Colortronic Ltd. – (LUXOR CA S Crystallizer, METRO G Crystallizing Loader) Paul Mueller Company – (Skid-Mounted Crystallizer System, Sanitary Batch Crystallizer) Vattenfall AB – (Electric Boiler for District Heating, Power-to-Heat Industrial Boiler System) Industrial Crystallizers Market Report Scope: Report Attributes Details Market Size in 2023 USD 3.91 Billion Market Size by 2032 USD 5.87 Billion CAGR CAGR of 4.67% From 2024 to 2032 Base Year 2023 Forecast Period 2024-2032 Historical Data 2020-2022 Report Scope & Coverage Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook Key Segments • By Type – (DTB Crystallizers, Forced Circulation Crystallizers, Fluidized Bed Crystallizers, Others)• By Process – (Continuous, Batch)• By End-Use Industry – (Pharmaceutical, Agrochemical, Metal & Mineral, Food & Beverage, Chemical, Wastewater Treatment, Others) Key Drivers • Rising Adoption of Crystallization in Wastewater Treatment Drives the Industrial Crystallizers Market Growth. If You Need Any Customization on Industrial Crystallizers Market Report, Inquire Now @ Key Segments Driving Growth in the Industrial Crystallizers Market: Insights by Type, Process, and End-Use Industry By Type: In terms of type, the Forced Circulation Crystallizers segment led the industrial crystallizers market with a 41.29% revenue share in 2023. The domination of this segment is due to the high processing efficiency of a large volume and corrosive solution. Its forced circulation design provides an efficient means of heat removal, resulting in reproducible crystallization behavior during extreme operational conditions. Such characteristics make them especially appropriate for the chemical and pharmaceutical, and food processing industries, where it is necessary to work with aggressive solvents and in high-throughput operations. By Process: The Continuous segment led the industrial crystallizers market in 2023 with a revenue share of 60.58%. This process ensures high efficiency in mass production and constant quality of product, leading to this leadership. Chemicals, fertilizers, and other high-demand sectors, where production must be uninterrupted and in large quantities for cost-effectiveness, highly value the continuous crystallization process. It enables a constant flow of operation, where the downtime is statistically negligible and output is maximized. With more industries emphasizing efficiency and scale, continuous crystallizers will keep their title as the equipment of choice for applications that demand a steady supply of quality crystallized end-products. By End-Use Industry: In 2023, the Chemical industry accounted for the highest revenue share in the market for industrial crystallizers, given its requirement for large-scale separation and purification operations. As a result, the industry has a high demand for industrial-scale separation and purification processes where crystallization is a pivotal process technology. Examples, including chemicals, pharmaceuticals, and specialty materials, often require specific purity levels that can only be achieved through precise crystallization. Industrial crystallizers are essential to the chemical sector due to their capability to rapidly isolate elements from lithified mixtures and maintain product quality reliability. Asia Pacific Dominates Industrial Crystallizers Market, North America Poised for Rapid Growth In 2023, the Asia Pacific region held the highest revenue share of 39.68% in the industrial crystallizers market, which was mainly supported by the high growth of major industries like chemicals, pharmaceuticals, and wastewater treatment, particularly in China, India, and Southeast Asia. The use of industrial crystallizers for separation & purification in these end-use industries will drive the market demand. The growing manufacturing and production sector in these countries has resulted in increased investment in infrastructure and technology, which is further driving the demand for effective crystallization. Thus, Expansion of the industrial base in the area contributes towards the growth of the market as industries require advanced technologies to streamline the process and meet regulatory standards. North America is expected to witness the highest compound annual growth rate (CAGR) of 6.23% in the industrial crystallizers market during the forecast period. This growth is mainly attributed to the modified environmental guidelines that encourage industries to organize efficient wastewater treatment systems. More stringent regulations are driving the need for advanced technologies in industrial crystallizers to comply with those regulations. Moreover, demand for crystallizers is accelerating due to the robust growth of the region's pharmaceutical sector. These systems are increasingly being adopted in the pharmaceutical sector, where precise crystallization processes are necessary for drug production. Recent Development In October 2024: Fives participated in Glasstec 2024, where it highlighted its decarbonized glass manufacturing solutions. The company demonstrated its electric melting technologies, hybrid systems, and oxy-fuel combustion solutions, all designed to reduce CO₂ emissions and improve energy efficiency in glass production. In May 2024: Moretto took part in Plastpol 2024, showcasing its latest innovations focused on energy efficiency, advanced technology, customization, and sustainability. The company presented its DGM Gravix series, renowned for its precision in dosing, and the DPK 8, which is engineered for micro-dosing applications in plastic Full Research Report on Industrial Crystallizers Market 2024-2032 @ Table of Contents – Major Key Points 1. Introduction 2. Executive Summary 3. Research Methodology 4. Market Dynamics Impact Analysis 5. Statistical Insights and Trends Reporting 6. Competitive Landscape 7. Industrial Crystallizers Market Segmentation, By Process 8. Industrial Crystallizers Market Segmentation, By End-Use Industry 9. Industrial Crystallizers Market Segmentation, By Type 10. Regional Analysis 11. Company Profiles 12. Use Cases and Best Practice 13. Conclusion Read Our Trending Reports: North America Led Industrial Air Filtration Market in 2023 with 44% Revenue Share Driven by Air Quality Awareness and Regulations North America Dominated Industrial Pumps Market with Over 43% Share in 2023 Driven by Chemical and Oil Industries Industrial Robotics Market in Europe Set for Significant Growth Driven by Collaborative Robots Enhancing Industrial Automation About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. CONTACT: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)Sign in to access your portfolio
Yahoo
4 days ago
- Business
- Yahoo
Industrial Crystallizers Market to Reach USD 5.87 Billion by 2032 with a CAGR of 4.67%, Driven by Demand for High-Purity Materials and Wastewater Treatment Innovations
Industrial Crystallizers Market is experiencing significant growth driven by the increasing need for high-purity substances in the chemical, pharmaceutical, and food industries. As industrial processes become more complex, crystallization technologies are essential for efficient separation and purification. Austin, May 27, 2025 (GLOBE NEWSWIRE) -- The Industrial Crystallizers Market Size was valued at USD 3.91 billion in 2023 and is expected to reach USD 5.87 billion by 2032, growing at a CAGR of 4.67% over the forecast period from 2024 to PDF Sample of Industrial Crystallizers Market @ The industrial crystallizers market is growing due to the need for high-purity substances, especially in the pharmaceuticals and chemicals industries. The rising use of crystallization technologies in the treatment of wastewater and the food industry also drives up market demand. Forced circulation systems and continuous processes are notable advancements in crystallizer design and are finding their way into mass production owing to their improved efficiency, scalability, higher yield quality consistency, as well as secondary treatment mechanisms, which are driving growth in the key regions across the globe. U.S. Industrial Crystallizers Market to Reach USD 1.07 Billion by 2032 with 6.15% CAGR The U.S. Industrial Crystallizers Market reached USD 0.63 billion in 2023 and is expected to reach USD 1.07 billion by 2032, advancing at a CAGR of 6.15% from 2024 to 2032. The U.S. market for industrial crystallizers is a key driver of global growth, spurred by innovation in chemical production, pharmaceuticals, and wastewater treatment. Key Players: Tsukishima Kikai – (OS Crystallizer, Vacuum Cooling Crystallizer) Fives Group – (Evaporative Crystallizer, Solios Forced Circulation Crystallizer) Condorchem Envitech – (ENVIDEST MVR FC Crystallizer, Vacuum Crystallization Plant) Vobis LLC – (Pilot Plant Crystallizer, Continuous Crystallizer System) Anssen Metallurgy Group Co., Ltd. – (Vacuum Salt Crystallizer, Evaporation & Crystallization System) Boardman LLC – (Forced Circulation Crystallizer, Industrial Heat Exchanger Crystallizer) Chemin Enviro Systems Pvt. Ltd. – (Forced Circulation Crystallizer, Agitated Thin Film Dryer-Crystallizer Combo) DCI, Inc. – (Batch Crystallizer Tank, Jacketed Stainless Steel Crystallizer) Ebner GmbH & Co. KG – (Vacuum Crystallizer, Controlled Cooling Crystallizer) Ekato Holding GmbH – (EKATO ISOPAS Crystallizer, EKATO UNIMIX Processing Crystallizer) Excel Engineering – (MS ZLD Crystallizer, Multiple Effect Evaporator with Crystallizer) GEA Group – (GEA MSE Crystallizer, VARICHEMA Batch Crystallizer) Katsuragi Industry Co., Ltd. – (Stainless Steel Crystallizer Tank, Continuous Crystallizing Unit) KEP Engineering Services Pvt. Ltd. – (Forced Circulation Crystallizer, Agitated Crystallizer) Moretto S.p.A. – (XD 800 X Dryer-Crystallizer, DEGA Thermal Crystallizer) Motan Colortronic Ltd. – (LUXOR CA S Crystallizer, METRO G Crystallizing Loader) Paul Mueller Company – (Skid-Mounted Crystallizer System, Sanitary Batch Crystallizer) Vattenfall AB – (Electric Boiler for District Heating, Power-to-Heat Industrial Boiler System) Industrial Crystallizers Market Report Scope: Report Attributes Details Market Size in 2023 USD 3.91 Billion Market Size by 2032 USD 5.87 Billion CAGR CAGR of 4.67% From 2024 to 2032 Base Year 2023 Forecast Period 2024-2032 Historical Data 2020-2022 Report Scope & Coverage Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook Key Segments • By Type – (DTB Crystallizers, Forced Circulation Crystallizers, Fluidized Bed Crystallizers, Others)• By Process – (Continuous, Batch)• By End-Use Industry – (Pharmaceutical, Agrochemical, Metal & Mineral, Food & Beverage, Chemical, Wastewater Treatment, Others) Key Drivers • Rising Adoption of Crystallization in Wastewater Treatment Drives the Industrial Crystallizers Market Growth. If You Need Any Customization on Industrial Crystallizers Market Report, Inquire Now @ Key Segments Driving Growth in the Industrial Crystallizers Market: Insights by Type, Process, and End-Use Industry By Type: In terms of type, the Forced Circulation Crystallizers segment led the industrial crystallizers market with a 41.29% revenue share in 2023. The domination of this segment is due to the high processing efficiency of a large volume and corrosive solution. Its forced circulation design provides an efficient means of heat removal, resulting in reproducible crystallization behavior during extreme operational conditions. Such characteristics make them especially appropriate for the chemical and pharmaceutical, and food processing industries, where it is necessary to work with aggressive solvents and in high-throughput operations. By Process: The Continuous segment led the industrial crystallizers market in 2023 with a revenue share of 60.58%. This process ensures high efficiency in mass production and constant quality of product, leading to this leadership. Chemicals, fertilizers, and other high-demand sectors, where production must be uninterrupted and in large quantities for cost-effectiveness, highly value the continuous crystallization process. It enables a constant flow of operation, where the downtime is statistically negligible and output is maximized. With more industries emphasizing efficiency and scale, continuous crystallizers will keep their title as the equipment of choice for applications that demand a steady supply of quality crystallized end-products. By End-Use Industry: In 2023, the Chemical industry accounted for the highest revenue share in the market for industrial crystallizers, given its requirement for large-scale separation and purification operations. As a result, the industry has a high demand for industrial-scale separation and purification processes where crystallization is a pivotal process technology. Examples, including chemicals, pharmaceuticals, and specialty materials, often require specific purity levels that can only be achieved through precise crystallization. Industrial crystallizers are essential to the chemical sector due to their capability to rapidly isolate elements from lithified mixtures and maintain product quality reliability. Asia Pacific Dominates Industrial Crystallizers Market, North America Poised for Rapid Growth In 2023, the Asia Pacific region held the highest revenue share of 39.68% in the industrial crystallizers market, which was mainly supported by the high growth of major industries like chemicals, pharmaceuticals, and wastewater treatment, particularly in China, India, and Southeast Asia. The use of industrial crystallizers for separation & purification in these end-use industries will drive the market demand. The growing manufacturing and production sector in these countries has resulted in increased investment in infrastructure and technology, which is further driving the demand for effective crystallization. Thus, Expansion of the industrial base in the area contributes towards the growth of the market as industries require advanced technologies to streamline the process and meet regulatory standards. North America is expected to witness the highest compound annual growth rate (CAGR) of 6.23% in the industrial crystallizers market during the forecast period. This growth is mainly attributed to the modified environmental guidelines that encourage industries to organize efficient wastewater treatment systems. More stringent regulations are driving the need for advanced technologies in industrial crystallizers to comply with those regulations. Moreover, demand for crystallizers is accelerating due to the robust growth of the region's pharmaceutical sector. These systems are increasingly being adopted in the pharmaceutical sector, where precise crystallization processes are necessary for drug production. Recent Development In October 2024: Fives participated in Glasstec 2024, where it highlighted its decarbonized glass manufacturing solutions. The company demonstrated its electric melting technologies, hybrid systems, and oxy-fuel combustion solutions, all designed to reduce CO₂ emissions and improve energy efficiency in glass production. In May 2024: Moretto took part in Plastpol 2024, showcasing its latest innovations focused on energy efficiency, advanced technology, customization, and sustainability. The company presented its DGM Gravix series, renowned for its precision in dosing, and the DPK 8, which is engineered for micro-dosing applications in plastic Full Research Report on Industrial Crystallizers Market 2024-2032 @ Table of Contents – Major Key Points 1. Introduction 2. Executive Summary 3. Research Methodology 4. Market Dynamics Impact Analysis 5. Statistical Insights and Trends Reporting 6. Competitive Landscape 7. Industrial Crystallizers Market Segmentation, By Process 8. Industrial Crystallizers Market Segmentation, By End-Use Industry 9. Industrial Crystallizers Market Segmentation, By Type 10. Regional Analysis 11. Company Profiles 12. Use Cases and Best Practice 13. Conclusion Read Our Trending Reports: North America Led Industrial Air Filtration Market in 2023 with 44% Revenue Share Driven by Air Quality Awareness and Regulations North America Dominated Industrial Pumps Market with Over 43% Share in 2023 Driven by Chemical and Oil Industries Industrial Robotics Market in Europe Set for Significant Growth Driven by Collaborative Robots Enhancing Industrial Automation About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. CONTACT: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Yahoo
4 days ago
- Business
- Yahoo
Thin Film Drug Manufacturing Business Research Report 2025: Market to reach $23.8 Billion by 2030 - Growing Focus on Enhancing Bioavailability and Drug Absorption Strengthens Business
Key drivers include demand for innovative drug delivery systems and patient-centric formulations. Technological advancements and collaborations are enhancing manufacturing processes. Significant growth is expected in segments like Oral Thin Film, and regions such as the U.S. and China. Major players include Allergan, IntelGenx, and Novartis. This report offers comprehensive market data, trends, and strategic insights. Thin Film Drug Manufacturing Market Dublin, May 27, 2025 (GLOBE NEWSWIRE) -- The "Thin Film Drug Manufacturing - Global Strategic Business Report" report has been added to global market for Thin Film Drug Manufacturing was valued at US$15.4 Billion in 2024 and is projected to reach US$23.8 Billion by 2030, growing at a CAGR of 7.6% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Thin Film Drug Manufacturing market. The global adoption of thin film drug manufacturing is driven by the increasing demand for novel drug delivery systems and the growing need for patient-centric formulations. As the pharmaceutical industry continues to explore innovative approaches to enhance drug efficacy and improve patient experiences, thin film technologies are gaining traction. These formulations offer benefits such as faster onset of action, improved bioavailability, and reduced side effects. Moreover, thin films can be tailored to deliver a wide range of drugs, including poorly soluble compounds and biologics, thereby addressing challenges associated with traditional drug delivery methods. The focus on patient-centric solutions, combined with advancements in manufacturing technologies, is propelling the growth of the global thin film drug manufacturing market. What Is Driving the Growth of the Global Thin Film Drug Manufacturing Market?The growth in the global Thin Film Drug Manufacturing market is driven by several factors, including rising investments in research and development for advanced drug delivery technologies, increasing collaborations between pharmaceutical companies and research institutions, and the growing focus on personalized medicine and patient-centric formulations. One of the primary growth drivers is the rising investment in research and development aimed at creating innovative drug delivery systems that enhance therapeutic efficacy. Pharmaceutical companies are increasingly allocating resources to explore thin film technologies as a means to improve drug formulations and address challenges associated with traditional delivery methods. This focus on R&D is fostering innovation in thin film drug manufacturing, driving demand as companies seek to differentiate their products and improve patient significant driver of market growth is the increasing collaborations between pharmaceutical companies, biotech firms, and research institutions to advance thin film drug technologies. Collaborative efforts are essential for accelerating the development of new formulations, sharing expertise, and accessing cutting-edge technologies. These partnerships are fostering innovation in thin film drug manufacturing by enabling the pooling of resources and knowledge to overcome technical challenges and streamline the development process. The rise of collaborative initiatives is expected to enhance the pace of innovation in the thin film drug manufacturing sector, contributing to market the growing focus on personalized medicine and patient-centric formulations is supporting the growth of the thin film drug manufacturing market. As healthcare moves towards more tailored treatment approaches, there is a demand for drug delivery systems that can accommodate individual patient needs and preferences. Thin film formulations offer versatility in terms of dosing, formulation design, and delivery routes, making them suitable for personalized medicine applications. The emphasis on creating patient-centric solutions that enhance adherence and improve therapeutic outcomes is driving the adoption of thin film technologies in various therapeutic areas. This trend is particularly strong in areas such as pain management, where individualized treatment regimens are essential for optimal patient advancements in technology and manufacturing processes are shaping the growth of the thin film drug manufacturing market. The increasing availability of advanced manufacturing techniques, such as roll-to-roll processing and continuous manufacturing, is enabling the efficient production of thin films at scale. These innovations are reducing production costs and improving the quality and consistency of thin film formulations. As manufacturers leverage these technological advancements to enhance production capabilities, the adoption of thin film drug manufacturing is expected to rise. As these factors continue to influence the thin film drug manufacturing landscape, the market is poised for robust growth, driven by rising investments in R&D for advanced drug delivery technologies, increasing collaborations between pharmaceutical companies and research institutions, and a growing focus on personalized medicine and patient-centric formulations. What Factors Are Driving the Adoption of Thin Film Drug Manufacturing Across Various Pharmaceutical Segments?The adoption of thin film drug manufacturing is being driven by several key factors, including the increasing demand for innovative drug delivery systems, the rising prevalence of chronic diseases, and the growing focus on patient compliance and convenience. One of the primary drivers is the increasing demand for innovative drug delivery systems that provide improved therapeutic outcomes. As the pharmaceutical industry evolves, there is a significant push towards developing formulations that enhance bioavailability and improve the pharmacokinetic profiles of drugs. Thin film drug delivery systems meet these demands by offering rapid dissolution and absorption, allowing for faster onset of action and improved patient outcomes. The need for innovative delivery systems is driving the adoption of thin film technologies in various therapeutic areas, including pain management, cardiovascular diseases, and significant factor influencing the adoption of thin film drug manufacturing is the rising prevalence of chronic diseases that require long-term treatment and management. Chronic conditions, such as diabetes, hypertension, and cancer, often necessitate frequent dosing or complex treatment regimens, making patient adherence a critical issue. Thin film formulations provide a user-friendly alternative to traditional dosage forms, allowing patients to easily take their medication without the need for water or complex administration processes. This convenience is particularly beneficial for elderly patients and those with mobility challenges. The growing emphasis on improving patient adherence and outcomes in chronic disease management is driving the demand for thin film drug delivery the expanding applications of thin film drug manufacturing in emerging markets are driving their adoption across various pharmaceutical segments. As healthcare infrastructure improves and access to medications increases in developing regions, the demand for innovative drug delivery solutions is expected to rise. Manufacturers are exploring thin film technologies to cater to the specific needs of these markets, including the development of affordable and accessible formulations. The potential for thin films to address unmet medical needs in emerging markets is creating new opportunities for growth in the thin film drug manufacturing ScopeKey Insights: Market Growth: Understand the significant growth trajectory of the Oral Thin Film segment, which is expected to reach US$9.9 Billion by 2030 with a CAGR of a 7.5%. The Transdermal Thin Film segment is also set to grow at 8.3% CAGR over the analysis period. Regional Analysis: Gain insights into the U.S. market, valued at $4.3 Billion in 2024, and China, forecasted to grow at an impressive 7.3% CAGR to reach $3.7 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific. Report Features: Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030. In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Company Profiles: Coverage of players such as Allergan plc, Indivior plc, IntelGenx Corp., MonoSol Rx, Novartis AG and more. Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments. Tariff Impact Analysis: Key Insights for 2025What's Included in This Edition: Tariff-adjusted market forecasts by region and segment Analysis of cost and supply chain implications by sourcing and trade exposure Strategic insights into geographic shifts Buyers receive a free July 2025 update with: Finalized tariff impacts and new trade agreement effects Updated projections reflecting global sourcing and cost shifts Expanded country-specific coverage across the industry Key Attributes: Report Attribute Details No. of Pages 197 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $15.4 Billion Forecasted Market Value (USD) by 2030 $23.8 Billion Compound Annual Growth Rate 7.6% Regions Covered Global Key Topics Covered: MARKET OVERVIEW Influencer Market Insights Tariff Impact on Global Supply Chain Patterns Thin Film Drug Manufacturing - Global Key Competitors Percentage Market Share in 2024 (E) Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E) MARKET TRENDS & DRIVERS Rising Demand for Fast-Dissolving and Patient-Friendly Drug Delivery Systems Drives Growth of Thin Film Drug Manufacturing Increased Adoption of Thin Film Drugs in Pediatric and Geriatric Populations Expands Addressable Market Growing Focus on Enhancing Bioavailability and Drug Absorption Strengthens Business Case for Thin Film Drug Manufacturing Rising Adoption of Thin Film Drugs in Motion Sickness, Cough, and Cold Treatments Sets the Stage for Market Expansion Increased Use of Thin Film Drug Manufacturing in Over-the-Counter (OTC) Pharmaceuticals Bodes Well for Market Growth Expansion of Thin Film Drug Manufacturing in Nutraceuticals and Dietary Supplements Expands Market Opportunities Increased Adoption of Thin Film Drugs in Antidepressants and Anti-Anxiety Medications Strengthens Market Opportunities Surge in Demand for Thin Film Drug Delivery Solutions in Veterinary Medicine Fuels Market Demand Growing Use of Thin Film Drugs in Tobacco Cessation and Nicotine Replacement Therapy Expands Market Opportunities Technological Advancements in Buccal and Sublingual Film Delivery Methods Propel Market Growth FOCUS ON SELECT PLAYERS:Some of the 47 companies featured in this report Allergan plc Indivior plc IntelGenx Corp. MonoSol Rx Novartis AG Pfizer, Inc. Solvay Sumitomo Dainippon Pharma Co., Ltd. Wolters Kluwer ZIM Laboratories Limited For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Thin Film Drug Manufacturing Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
Irish Post
24-04-2025
- Entertainment
- Irish Post
Rising Irish star Nell Mescal will support Robbie Williams at UK festival
IRISH singer-songwriter Nell Mescal has revealed she will support Robbie William at a UK festival in June. The 21-year-old rising star, who hails from Maynooth in Co. Kildare, says she is 'beyond excited' as she revealed her busy summer schedule, which includes performing ahead of William's gig at the Come Together Festival in Newcastle. 'I'm beyond excited for what's to come,' the young star, who is the younger sister of Gladiator II star Paul Mescal, said. Nell Mescal has released her new track Thin (Pic: Sophie Scott) 'I have lots of new music that I'm currently working on, which will be out soon,' she added, 'and I'll be playing festivals this summer and working on a run of headline shows for you all later in the year.' This week London-based Mescal released her new demo Thin, which she claims was 'really difficult' to write. 'Thin is about body image and equating what you look like to what your worth is when it comes to love,' she explained. 'It was a really difficult song to write and to confront and comes from all my darkest and most untrue thoughts about myself.' She added: 'The ultimate message of the song and what I hope people get from listening to it is that these thoughts aren't true, but that doesn't make the emotions any less real and that you are enough as you are.' The track is Mescal's first release since her debut EP Can I Miss It For A Minute? In May 2024. The singer has kept busy in the meantime, enjoying sellout headline shows in New York last month, a support slot with Dermot Kennedy at Misneach Festival in Boston, and performing a string of intimate acoustic gigs. As well as her slot with Williams on June 4, Mescal will perform with her band at festivals across the summer. In the past she has performed at Latitude, All Points East, and Electric Picnic and supporting a range of acts, including HAIM, Florence & The Machine, Dermot Kennedy, and The Last Dinner Party. See More: Ireland, Nell Mescal, Paul Mescal, Robbie Williams, Tour, UK
Globe and Mail
14-04-2025
- Business
- Globe and Mail
The U.S. Economy Is ‘Nowhere Near the End of the Storm,' Says Wall Street Investor
The U.S. economy is 'nowhere near the end of the storm,' according to Win Thin, head of currency strategy at Brown Brothers Harriman. Speaking to CNBC, Thin said the idea that the U.S. economy is uniquely strong no longer holds true. He explained that earlier pro-growth policies like tax cuts and deregulation have been replaced with new measures like tariffs, deportations, and layoffs tied to the Department of Government Efficiency. These shifts have added a lot of uncertainty to the markets and made investors nervous. Stay Ahead of the Market: Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener. Thin also pointed out that the market is acting unusually. Normally, when there's economic trouble, the U.S. dollar (UUP) gets stronger, but right now, it is actually getting weaker while Treasury yields are rising, which is not typical. He said that recent Treasury auctions have gone well, but there are growing worries about the U.S. becoming a less attractive place to invest because of unpredictable policy changes. 'Markets like certainty, they hate uncertainty,' Thin said. Interestingly, Thin called the dollar's recent weakness 'cyclical' and 'man-made' and blamed it on three months of unpredictable government actions. As a result, he said that it will take time and more stability from Washington in order to rebuild trust with investors. Thin believes the U.S. is just beginning to deal with these challenges and that the usual market signals are no longer behaving as expected. Is SPY a Buy Right Now? Turning to Wall Street, analysts have a Moderate Buy consensus rating on the SPDR S&P 500 ETF Trust (SPY) based on 412 Buys, 84 Holds, and eight Sells assigned in the past three months, as indicated by the graphic below. Furthermore, the average SPY price target of $671.82 per share implies 25.2% upside potential. See SPY's holdings
